The first ever immunotherapy treatment for a rare form of aggressive head and neck cancer causing facial disfigurement has ...
Melbourne man Ralph Markham’s life was transformed by love and, later, a devastating cancer diagnosis. Now, he is hoping new ...
SAGA Diagnostics, a pioneer in blood-based cancer detection and precision medicine redefining the standard for ultra-sensitive and early molecular residual disease (MRD) detection, will present five ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...
Immunotherapy-chemotherapy combination of eftilagimod alfa (efti) and paclitaxel led to strong objective response rates and ...
A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment—an advance ...
According to Precedence Research, the global oncology market size was valued at USD 250.88 billion in 2025 and will grow from ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
The global T-Cell lymphoma therapeutics market size was valued at US$ 2.3 Bn in 2024 and is projected to reach US$ 5.7 Bn by ...
Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
When seven-month-old Evelyn was diagnosed with a rare cancer, her mother was told proton beam therapy would be her daughter's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback